Activation of AP-1 by okadaic acid in mouse keratinocytes associated with hyperphosphorylation of c-jun

Molecular Carcinogenesis

Volumn 18, Issue 1, 1997, Pages 37-43

  Peng, Jiexin ^a   Bowden, G Tim ^b   Domann, Frederick E ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

c jun; phosphatase inhibitor; phosphorylation; tumor promotion

Indexed keywords

OKADAIC ACID;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; KERATINOCYTE; MOUSE; NONHUMAN; ONCOGENE C JUN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DNA BINDING; REGULATORY MECHANISM; TUMOR PROMOTION;

ANIMALS; CARCINOGENS; CELL LINE; DNA; ENZYME INHIBITORS; KERATINOCYTES; MICE; OKADAIC ACID; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-JUN; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1;

ANIMALIA;

EID: 0031036940     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199701)18:1<37::AID-MC5>3.0.CO;2-O     Document Type: Article

References (40)

1. Suganuma M, Fujiki H, Suguri H, et al. Okadaic acid: An additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter. Proc Natl Acad Sci USA 85:1768-1771, 1988.
2. Bialojan C, Takai A. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem J 256:283-290, 1988.
3. Nishiwaki S, Fujiki H, Suganuma M, et al. Structure-activity relationship within a series of okadaic acid derivatives. Carcinogenesis 11:1837-1841, 1990.
4. Issinger OG, Martin T, Richter WW, Olson M, Fujiki H. Hyperphosphorylation of N-60, a protein structurally and immunologically related to nucleolin after tumour-promoter treatment. EMBO J 7:1621-1626, 1988.
5. Sassa T, Richter WW, Uda N, et al. Apparent "activation" of protein kinases by okadaic acid class tumor promoters. Biochem Biophys Res Commun 159:939-944, 1989.
6. Kim SJ, Lafyatis R, Kim KY, et al. Regulation of collagenase gene expression by okadaic acid, an inhibitor of protein phosphatases. Cell Reg 1:269-278, 1990.
7. Thevenin C, Kim SJ, Rieckmann P, et al. Induction of nuclear factor-kappa B and the human immunodeficiency virus long terminal repeat by okadaic acid, a specific inhibitor of phosphatases 1 and 2A. New Biol 2:793-800, 1990.
8. Thevenin C, Kim SJ, Kehrl JH. Inhibition of protein phosphatases by okadaic acid induces AP1 in human T cells. J Biol Chem 266:9363-9366, 1991.
9. Fujiki H, Suganuma M, Nishiwaki S, et al. A new pathway of tumor promotion by the okadaic acid class compounds. Adv Second Messenger Phosphoprotein Res 24:340-344, 1990.
10. Chiu R, Boyle WJ, Meek J, Smeal T, Hunter T, Karin M. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 54:541-552, 1988.
11. Rauscher F3, Cohen DR, Curran T, et al. Fos-associated protein p39 is the product of the jun proto-oncogene. Science 240:1010-1016, 1988.
12. Angel P, Allegretto EA, Okino ST, et al. Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature 332:166-171, 1988.
13. Angel P, Imagawa M, Chiu R, et al. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729-739, 1987.
14. Bohmann D, Bos TJ, Admon A, Nishimura T, Vogt PK, Tjian R. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 238:1386-1392, 1987.
15. Black EJ, Street AJ, Gillespie DA. Protein phosphatase 2A reverses phosphorylation of c-Jun specified by the delta domain in vitro: Correlation with oncogenic activation and deregulated transactivation activity of v-Jun. Oncogene 6:1949-1958, 1991.
16. Hunter T, Karin M. The regulation of transcription by phosphorylation. Cell 70:375-387, 1992.
17. Sluss HK, Barrett T, Derijard B, Davis RJ. Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol Cell Biol 14:8376-8384, 1994.
18. Domann FE, Levy JP, Birrer MJ, Bowden GT. Stable expression of a c-JUN deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice. Cell Growth Differ 5:9-16, 1994.
19. Dong Z, Birrer MJ, Watts RG, Matrisian LM, Colburn NH. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc Natl Acad Sci USA 91:609-613, 1994.
20. Strickland JE, Greenhalgh DA, Koceva-Chyla A, et al. Development of murine epidermal cell lines which contain an activated rasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts. Cancer Res 48:165-169, 1988.
21. Domann FE, Levy JP, Finch JS, Bowden GT. Constitutive AP-1 DNA binding and transactivating ability of malignant but not benign mouse epidermal cells. Mol Carcinog 9:61-66, 1994.
22. Holladay K, Fujiki H, Bowden GT. Okadaic acid induces the expression of both early and secondary response genes in mouse keratinocytes. Mol Carcinog 5:16-24, 1992.
23. Angel P, Hattori K, Smeal T, Karin M. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55:875-885, 1988.
24. Sassone CP, Sisson JC, Verma IM. Transcriptional autoregulation of the proto-oncogene fos. Nature 334:314-319, 1988.
25. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489, 1983.
26. Stein B, Angel P, van Dam H, et al. Ultraviolet-radiation induced c-jun gene transcription: Two AP-1 like binding sites mediate the response. Photochem Photobiol 55:409-415, 1992.
27. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
28. Pulverer BJ, Kyriakis JM, Aruch J, Nikolakaki E, Woodgett JR. Phosphorylation of c-Jun mediated by MAP kinases. Nature 353:670-674, 1991.
29. Lee JS, Favre B, Hemmings BA, Kiefer B, Nagamine Y. Okadaic acid-dependent induction of the urokinase-type plasminogen activator gene associated with stabilization and autoregulation of c-Jun. J Biol Chem 269:2887-2894, 1994.
30. Devary Y, Gottlieb RA, Lau LF, Karin M. Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol Cell Biol 11:2804-2811, 1991.
31. Rosenberger SF, Bowden GT. Okadaic acid stimulated TRE binding activity in a papilloma producing mouse keratinocyte cell line involves increased AP-1 expression. Oncogene 12:1301-1308, 1996.
32. van Dam H, Duyndam M, Rottier R, et al. Heterodimer formation of dun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. EMBO J 12:479-487, 1993.
33. Herr I, van Dam H, Angel P. Binding of promoter-associated AP-1 is not altered during induction and subsequent repression of the c-jun promoter by TPA and UV irradiation. Carcinogenesis 15:1105-1113, 1994.
34. Alberts AS, Deng T, Lin A, et al. Protein phosphatase 2A potentiates activity of promoters containing AP-1 binding elements. Mol Cell Biol 13:2104-2112, 1993.
35. Haby C, Aunis D, Zwiller J. Okadaic acid induces activator protein 1 activity and immediate early gene transcription in rat pheochromocytoma cells. Mechanism of action. Biochem Pharmacol 48:819-825, 1994.
36. Binetruy B, Smeal T, Karin M. Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain. Nature 351:122-127, 1991.
37. Boyle WJ, Smeal T, Defize LH, et al. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell 64:573-584, 1991.
38. Papavassiliou AG, Treier M, Bohmann D. Intramolecular signal transduction in c-Jun. EMBO J 14:2014-2019, 1995.
39. Bernstein LR, Colburn NH. AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science 244:566-569, 1989.
40. Briata P, Danna F, Franzi AT, Gherzi R. AP-1 activity during normal human keratinocyte differentiation: Evidence for a cytosolic modulator of AP-1/DNA binding. Exp Cell Res 204:136-146, 1993.